CryoLife makes Medtronic executive Mackin CEO
This article was originally published in Clinica
Executive Summary
CryoLife, which specializes in providing preserved human cardiac and vascular tissues for surgery, has appointed James Patrick (Pat) Mackin president and CEO. He joins from medtech giant Medtronic, where he worked since 2002, most recently as president of cardiac rhythm disease management, the firm’s largest operating division. Mr Mackin will join CryoLife on 2 September, replacing outgoing chief Steven Anderson, who will remain at the company as chair. Before joining Medtronic, Mr Mackin was at Genzyme for six years, and he also served in the US Army.